Osteoporosis Treatment Now Approved In Europe And US For Men (Medical News Today)
The US Food and Drug Administration (FDA) this week approved Actonel® 35mg (risedronate sodium tablets) for 'treatment to increase bone mass in men with osteoporosis'. This follows the positive outcome in July 2006 of the European application for the additional indication of 'treatment of osteoporosis in men at high risk of fracture'. [click link for full article]

St. Jude Medical Announces FDA Approval and Launch of QuickOpt(TM) Timing Cycle Optimization for Heart Failure and ICD (RedNova)
St. Jude Medical, Inc. (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) approval and launch of QuickOpt(TM) Timing Cycle Optimization.

Possis Receives FDA Clearance for GuardDOG(R) Occlusion System; New Device Allows Physicians to Quickly and Effectively (RedNova)
Possis Medical, Inc. (NASDAQ:POSS), today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its GuardDOG(R) Occlusion System for use during the treatment of peripheral vascular disease.